LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF7 | Y39983 | 0.1996 |
| MCF7 | YM 201636 | 0.3286 |
| MCF7 | ZSTK474 | 0.8126 |
| MDA-MB-231 | Seliciclib | 0.1342 |
| MDA-MB-231 | A443654 | 0.9761 |
| MDA-MB-231 | Afatinib | 0.3747 |
| MDA-MB-231 | AT-7519 | 1.0642 |
| MDA-MB-231 | AZD 5438 | 0.8090 |
| MDA-MB-231 | AZD-6482 | 0.2211 |
| MDA-MB-231 | AZD7762 | 0.9032 |
| MDA-MB-231 | AZD8055 | 0.7676 |
| MDA-MB-231 | AZD8330 | 0.9253 |
| MDA-MB-231 | Barasertib | 0.8612 |
| MDA-MB-231 | Dactolisib | 0.7487 |
| MDA-MB-231 | BI-2536 | 0.9961 |
| MDA-MB-231 | SNS-032 | 1.1679 |
| MDA-MB-231 | BMS345541 | 0.3729 |
| MDA-MB-231 | Brivanib | 0.1066 |
| MDA-MB-231 | Buparlisib | 0.4364 |
| MDA-MB-231 | BX-912 | 0.4666 |
| MDA-MB-231 | Alpelisib | 0.0780 |
| MDA-MB-231 | Canertinib | 0.2722 |
| MDA-MB-231 | Celastrol | 0.5688 |
| MDA-MB-231 | CGP60474 | 1.1949 |
| MDA-MB-231 | CHIR-99021 | 0.1690 |